Evaluation of the impact of a new synthetic vitamin E-bonded membrane on anemia and rHuEPO requirement in ESRD patients with central venous catheters: A pilot study

International Urology and Nephrology

Volumn 44, Issue 5, 2012, Pages 1493-1500

  Mandolfo, S ^a   Corradi, B ^a   Bucci, R ^a   Farina, M ^a   Pilolli, F ^b   Galli, F ^b  

^a Renal Unit   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Anemia; Central venous catheter; ESA index; Hemodialysis; Inflammation; Oxidative stress; rHuEPO; Vitamin E coated membrane

Indexed keywords

ALPHA TOCOPHEROL; ANTIANEMIC AGENT; ANTIOXIDANT; C REACTIVE PROTEIN; GAMMA TOCOPHEROL; HEMOGLOBIN; POLYETHERSULFONE; RECOMBINANT ERYTHROPOIETIN;

AGED; ANEMIA; ARTICLE; ARTIFICIAL KIDNEY; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG USE; ERYTHROPOIESIS; ERYTHROPOIESIS STIMULATING AGENTS INDEX; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; MALE; PILOT STUDY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN GLYCOXIDATION; PROTEIN MODIFICATION; TREATMENT DURATION; TREATMENT RESPONSE; VITAMIN BLOOD LEVEL; VITAMIN E BONDED DIALYZER;

AGED; AGED, 80 AND OVER; ANEMIA; ANTIOXIDANTS; C-REACTIVE PROTEIN; CENTRAL VENOUS CATHETERS; COATED MATERIALS, BIOCOMPATIBLE; CROSS-OVER STUDIES; ERYTHROPOIETIN; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMATINICS; HEMOGLOBINS; HUMANS; INTERLEUKIN-1; KIDNEY FAILURE, CHRONIC; MEMBRANES, ARTIFICIAL; OXIDATIVE STRESS; PILOT PROJECTS; POLYMERS; RECOMBINANT PROTEINS; RENAL DIALYSIS; SULFONES; VITAMIN E;

EID: 84863326756     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-011-0016-9     Document Type: Article

References (36)

1. Ethier J, Mendelssohn DC, Elder SJ et al (2008) Vascular access use and outcomes: an international perspective: results from the dialysis outcomes and practice patterns study. Nephrol Dial Transplant 23(10):3219-3226
2. Hung AM, Ikizler T (2008) Hemodialysis central venous catheters as a source of inflammation and its implications. Semin Dial 21(5):401-404
3. Wystrychowski G, Kitzler TM, Thijssen S et al (2009) Impact of switch of vascular access type on key clinical and laboratory parameters in chronic haemodialysis patients. Nephrol Dial Transplant 24(7):2194-2200
4. Chand DH, Teo BW, Fatica RA et al (2008) Influence of vascular access type on outcome measures in patients on maintenance hemodialysis. Nephron Clin Pract 108:112
5. Movilli E, Brunori G, Camerini C et al (2006) The kind of vascular access influences the baseline inflammatory status and epoetin response in chronic hemodialysis patients. Blood Purif 24(4):387-393
6. Locatelli F, Aljama P, Barany P et al (2004) Revisited European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 19(S2):ii32-ii36
7. De Francisco AL, Stenvinkel P, Vaulont S (2009) Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness. Nephrol Dial Transplant 2(S1):i18-i26
8. Zadeh KK, Lee G, Miller J (2009) Predictors of Hypo responsiveness to erythropoiesis-stimulating agents in haemodialysis patients. Am J Kidney Dis 53(5):823-834
9. Galli F (2002) Vitamin E-modified dialysers. Contrib Nephrol 137:95-105
10. Satoh M, Yamasaki Y, Nagake Y et al (2001) Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters. Kidney Int 59(5):1943-1950
11. Morimoto H, Nakao K, Fukuoka K et al (2005) Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients. Nephrol Dial Trasplant 20(12):2775-2782
12. Usberti M, Gerardi G, Micheli A et al (2002) Effects of erythropoietin and vitamin E-modified membrane on plasma oxidative stress markers and anemia of hemodialyzed patients. Am J Kidney Dis 40(3):590-599
13. Sasaki M (2006) Development of vitamin E-modified polysulfone membrane dialyzers. Int J Artif Organs 9(1): 50-60
14. Floridi A, Piroddi M, Pilolli F et al (2009) Analysis method and characterization of the antioxidant capacity of vitamin E-interactive polysulfone hemodialyzers. Acta Biomater 5(8):2974-2982
15. Andrulli S, Di Filippo S, Manzoni C et al (2010) Effect of synthetic vitamin E-bonded membrane on responsiveness to erythropoiesis-stimulating agents in haemodialysis patients: a pilot study. Nephron Clin Pract 115:82-89
16. Matsumura M, Sasaki H, Sekizuka K et al (2010) Improved management of intradialytic hypotension (IDH) using vitamin E-bonded polysulfone membrane dialyzer. Int J Artif Organs 33(3):147-153
17. Daugirdas JT, Depner TA, Gotch FA et al (1997) Comparison of methods to predict equilibrated Kt/V in the HEMO pilot study. Kidney Int 52:1395-1405
18. Tattersall J, Martin-Malo A, Pedrini L et al (2007) EBPG guideline on dialysis strategies. Minimum adequate dialysis. Nephrol Dial Transplant 22(S22):ii5-ii21
19. Galli F, Benedetti S, Floridi A (2005) Glycoxidation and inflammatory markers in patients on treatment with PMMAbased protein-leaking dialyzers. Kidney Int 67:750-759
20. Floridi A, Trizza V, Paolotti P et al (1999) Analytical strategy for the assessment of the protein glycation status in uremic patients by high-performance liquid chromatography. J Chromatogr 846:65-71
21. Galli F (2007) Protein damage and inflammation in uraemia and dialysis patients. Nephrol Dial Transplant S5:20-36
22. Thornalley P, Rabbani N (2009) Highlights and hotspots of protein glycation in end-stage renal disease. Semin Dial 22:400-404
23. Piroddi M, Palazzetti I, Quintaliani G et al (2011) Circulating levels and dietary intake of the advanced glycation end-product marker carboxymethyl lysine in chronic kidney disease patients on conservative predialysis therapy: a pilot study. J Ren Nutr 21(4):329-339
24. Foley RN, Chen SC, Collins AJ (2009) Hemodialysis access at initiation in the US, 2005-2007: still "catheter first". Hemodial Int 13:533-542
25. Kanbay M, Perazella MA, Kasapoglu B et al (2010) Erythropoiesis stimulatory agent-resistant anemia in dialy sis patients: review of causes and management. Blood Purif 29(1):1-12
26. Usberti M, Gerardi G, Micheli A et al (2002) Effects of a vitamin E-bonded membrane and of glutathione on anemia and erythropoietin requirements in hemodialysis patients. J Nephrol 15(5):558-564
27. Locatelli F, Andrulli S, Memoli B et al (2006) Nutritionalinflammation status and resistance to erythropoietin therapy in haemodialysis patients. Nephrol Dial Transplant 21(4): 991-998
28. Gaweda AE, Goldsmith LJ, Brier ME et al (2010) Iron, inflammation, dialysis adequacy, nutritional status, and hyperparathyroidism modify erythropoietic response. Clin J Am Soc Nephrol 5(4):576-581
29. Johnson DW, Pollock CA, Macdougall IC (2007) Erythropoiesis-stimulating agent hyporesponsiveness. Nephrology 12(4):321-330
30. Elliott J, Mishler D, Agarwal R (2009) Hyporesponsiveness to erythropoietin: causes and management. Adv Chronic Kidney Dis 16(2):94-100
31. Nakatan T, Takemoto Y, Tsuchida AK (2003) The effect of vitamin E-bonded dialyzer membrane on red blood cell survival in hemodialyzed patients. Artif Organs 27(3):214-217
32. Kobayashi S, Moriya H, Aso K et al (2003) Vitamin E-bonded hemodialyzer improves atherosclerosis associated with a rheological improvement of circulating red blood cells. Kidney Int 63(5):1881-1887
33. Cruz DN, De Cal M, Garzotto F (2008) Effect of vitamin E-coated dialysis membranes on anemia in patients with chronic kidney disease: an Italian multicenter study. Int J Artif Organs 31(6):545-552
34. Galli F (2010) On the antiatherogenic effects of vitamin E: the search for the holy grail. Vasc Health Risk Manag 6:69-71
35. Panichi V, Barattini M, Angelini D et al (2011) A vitamin E-coated polysulfone membrane reduces inflammatory markers and EPO requirement in haemodialysis patients. Blood Purif 32(1):7-14
36. Locatelli F, Covic A, Eckardt KU et al (2009) Anaemia management in patients with chronic kidney disease: a position statement by the anaemia working group of european renal best practice (ERBP). Nephrol Dial Transplant 24(2):348-354